Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2020-11-26 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 6810G' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' It details a 'Price Monitoring Extension' which is a specific operational announcement related to trading on the exchange, not a comprehensive financial report, management change, or shareholder vote result. Since it is a general regulatory announcement disseminated via the RNS system that does not fit into the more specific categories (like DIV, ER, 10-K, etc.), the most appropriate classification is the general Regulatory Filings category.
2020-11-26 English
High clinical accuracy in India study
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated November 20, 2020. It announces the publication of study data for the Genedrive HCV ID Kit, detailing clinical accuracy results (100% sensitivity and specificity) and providing a link to the full publication. The text concludes with contact information and a disclaimer stating, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This structure—a brief announcement about new information being available elsewhere, distributed via RNS—strongly indicates a general regulatory announcement or press release that doesn't fit a more specific category like ER, IR, or 10-K. Since it is a general announcement distributed through the RNS system and doesn't fit the definitions for specific reports (like AR, IR, ER) or specific corporate actions (like DIV, CAP, DIRS), the most appropriate fallback category is Regulatory Filings (RNS). The document length (4549 chars) is not extremely short, but the content is purely an announcement of external data publication.
2020-11-20 English
Final Results
Regulatory Filings Classification · 1% confidence The document explicitly states it announces the "Audited Final Results for the year ended 30 June 2020." This content, which includes detailed Financial Highlights, Operational Highlights, Chairman's Statement, and CEO's Review covering the full fiscal year performance, strongly indicates a comprehensive annual report. Although it is presented via an RNS announcement format (suggesting RPA or RNS), the core content is the full annual financial results, which aligns best with the Annual Report (10-K) definition, even if the actual 10-K filing might follow separately or this serves as the primary disclosure for the period. Given the depth of the results summary, it is classified as the Annual Report content rather than just a publication announcement.
2020-11-17 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 8458E'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIRS, DIV, or DLST), the most appropriate fallback category is Regulatory Filings (RNS).
2020-11-10 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1914 characters) and contains the header 'RNS Number : 8444E' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form operational announcement related to trading mechanics, not a comprehensive financial report or a standard regulatory filing like a 10-K or ER. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIV, DIRS, ER, etc.), the most appropriate classification is the general regulatory filing fallback category, RNS.
2020-11-10 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. It uses the 'RNS Number' format and explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which is approved by the FCA. This type of brief, operational announcement regarding market mechanics or regulatory updates that don't fit specific financial reporting categories (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing or announcement, fitting the 'RNS' category.
2020-11-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.